Presentation TCT 2018 TCT-13: 5-Year Outcomes From the Randomized Corevalve USPivotal High Risk Trial: Final Results Presenter: Thomas Gleason September 21, 2018 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2018 Up Next Presentation TCT 2018 TCT-29: Procedural and Anatomic Predictors of Response in RADIANCE-HTN SOLO: A Multicenter, Randomized, Sham-Controlled Trial Of Endovascular Ultrasound Renal Denervation Presenter: Ajay J. Kirtane September 21, 2018 More slides + Presentation TCT 2018 TCT-21: Prognostic Impact of SYNTAX II Score in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Analysis of an 8-year All-Comers Registry Presenter: Ana Belen Cid Alvarez September 21, 2018 Presentation TCT 2018 New TAVR Devices: VitaFlow, Venus A Plus, and Venibri Presenter: Junbo Ge September 21, 2018 We Recommend
Presentation TCT 2018 TCT-29: Procedural and Anatomic Predictors of Response in RADIANCE-HTN SOLO: A Multicenter, Randomized, Sham-Controlled Trial Of Endovascular Ultrasound Renal Denervation Presenter: Ajay J. Kirtane September 21, 2018
Presentation TCT 2018 TCT-21: Prognostic Impact of SYNTAX II Score in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Analysis of an 8-year All-Comers Registry Presenter: Ana Belen Cid Alvarez September 21, 2018
Presentation TCT 2018 New TAVR Devices: VitaFlow, Venus A Plus, and Venibri Presenter: Junbo Ge September 21, 2018